Healthcare News

Updated CAMPX results show statistically significant DFU closure improvement with XWRAP® — accepted at SAWC Fall 2026.

PK/PD Data is from a Sub-Study in the Phase III TIGeR-PaC Clinical Trial  The Study Shows Approximately 51% Tumor-Site Drug Extraction, Decreased Systemic Exposure, and Significant Correlation...

Company on track to initiate SOTERIA trial in the second half of 2026 Clinical development activities advancing following FDA authorization, CRO engagement and Fast Track Designation across all four...

Nu-Tek rencontrera des dirigeants de l’industrie pharmaceutique lors du salon BioProcess International East, du 22 au 25 septembre à Boston, afin de discuter de peptones et d’hydrolysats de protéines...

Nu-Tek wird sich während der BioProcess International East vom 22. bis 25. September in Boston mit führenden Vertretern der Pharmabranche treffen, um über Peptone und Proteinhydrolysate zu sprechen,...

Nu-Tek BioSciences to Attend BPI East 2026 in Boston, Connecting Animal-Free Culture Media Nutrients with Pharma Customer Growth Strategies

DENVER, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Mixie Technologies, Inc. (OTC: MIXE) today announced that its portfolio company HoloTwin LLC has unveiled TwinRuntime, a browser-native digital twin runtime...

MALVERN, Pa., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...

ROCKAWAY, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a bioelectronic technology company, today announced that Truvaga, its non-invasive vagus nerve stimulation (nVNS)...

SOUTH SAN FRANCISCO, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug...